Objective This study aimed to assess implementation adherence (how well the patient’s actual intake matches the prescribed dosing regimen) to non-vitamin K antagonist oral anticoagulants (NOACs) and ...

Lipoprotein(a) (Lp(a)) is a complex circulating lipoprotein, and increasing evidence has demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) and as a possible ...

Objective D-dimer might serve as a marker of thrombogenesis and a hypercoagulable state following plaque rupture. Few studies explore the association between baseline D-dimer levels and the incidence ...

In 1772, William Heberden described ‘a disorder of the breast marked with strong and peculiar symptoms… [with a] sense of strangling and anxiety’. Individuals affected are ‘seized while they are ...

The management of atrial fibrillation (AF) has focused on anticoagulation, rhythm control and ventricular rate control. Recently, a fourth pillar of AF management has been incorporated recognising the ...

Background Resistance training (RT) for improving muscular strength is a fundamental part of the exercise component in Cardiac Rehabilitation (CR) protocols for post-open-heart surgeries. Although ...

Introduction The European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death recommend that subcutaneous ...

Methods Ten athletes were referred from external pre-participation screening. All exhibited prominent deep symmetrical T wave inversion in the inferolateral leads (figure 1). All had negative family ...

Background Both the insulin secretion and insulin resistance in Type 2 diabetes (T2D) are amenable to pharmacological intervention. promote insulin secretion, causes weight loss and is an important ...

Introduction Public reporting of 30-day mortality after percutaneous coronary intervention (PCI) imply that death after PCI is a complication for the interventional cardiologist and the hospital.

Results A total of 92 HCM patients were identified, with median follow up period 52 months, median age 56 years (range 15–86), and male sex in 64%. Twelve patients had an implantable cardioverter ...

Results The median percentage decrease in platelet count was 37.8% [IQR: 28.8–48.4], resulting in moderate (<100*109/L) and severe (<50*109/L) thrombocytopenia in 28.8% and 4.2% of patients, ...